# Tetragon Partners GP Ltd 13F holdings Q2 2026: $635 million

Tetragon Partners GP Ltd reported $635 million in 13F securities across 39 positions for the quarter ended June 30, 2026, in a holdings report filed August 13, 2026. Its largest holding was Uipath Inc at $336 million, 53.0% of the reported value. Since Q1 2026 it opened 10 new positions and exited 7.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $635,063,221
- Positions: 39
- Filed: August 13, 2026
- Report type: 13F holdings report
- CIK: 1515070
- Form 13F file number: 028-15287
- Business address: Po Box 309 Ugland House, Grand Cayman, KY1-1104 Cayman Islands
- SEC filing: [0000919574-26-005024](https://www.sec.gov/Archives/edgar/data/1515070/000091957426005024/0000919574-26-005024-index.htm)

## Top 25 holdings by value

The largest of 39 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Uipath Inc](https://specstream.ai/data/institutional-holders/uipath-inc-90364p105) | CL A | 30,950,000 | $336.4 million | +5,742,372 |
| [Kolibri Global Energy Inc](https://specstream.ai/data/institutional-holders/kolibri-global-energy-inc-50043k406) | COM NEW | 6,834,504 | $33.8 million | No change |
| [Autolus Therapeutics LTD](https://specstream.ai/data/institutional-holders/autolus-therapeutics-ltd-05280r100) | SPON ADS | 9,500,000 | $15.2 million | No change |
| [Lyft Inc](https://specstream.ai/data/institutional-holders/lyft-inc-55087p104) | CL A COM | 1,000,000 | $14.6 million | No change |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 286,990 | $13.5 million | +86,996 |
| [Workiva Inc](https://specstream.ai/data/institutional-holders/workiva-inc-98139a105) | COM CL A | 250,000 | $12.1 million | No change |
| [Sprinklr Inc](https://specstream.ai/data/institutional-holders/sprinklr-inc-85208t107) | CL A | 2,200,000 | $11.4 million | No change |
| [MBX Biosciences Inc](https://specstream.ai/data/institutional-holders/mbx-biosciences-inc-55287l101) | COM | 203,543 | $11.2 million | +58,063 |
| [Alkami Technology Inc](https://specstream.ai/data/institutional-holders/alkami-technology-inc-01644j108) | COM | 600,284 | $10.9 million | New |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 290,441 | $10.8 million | -21,875 |
| [Relay Therapeutics Inc](https://specstream.ai/data/institutional-holders/relay-therapeutics-inc-75943r102) | COM | 570,311 | $10.7 million | +388,768 |
| [Arrowhead Pharmaceuticals in](https://specstream.ai/data/institutional-holders/arrowhead-pharmaceuticals-in-04280a100) | COM | 130,484 | $10.6 million | +3,286 |
| [Pharvaris N V](https://specstream.ai/data/institutional-holders/pharvaris-n-v-n69605108) | COM | 295,627 | $10.2 million | +74,016 |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 189,979 | $10 million | +30,188 |
| [Immunovant Inc](https://specstream.ai/data/institutional-holders/immunovant-inc-45258j102) | COM | 255,934 | $9.9 million | +37,427 |
| Axsome Therapeutics Inc. | COM (call) | 35,000 | $8.6 million | No change |
| [Silence Therapeutics PLC](https://specstream.ai/data/institutional-holders/silence-therapeutics-plc-82686q101) | ADS | 764,256 | $8.4 million | +134,095 |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 356,657 | $7.9 million | +98,525 |
| [Ionis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ionis-pharmaceuticals-inc-462222100) | COM | 97,173 | $7.7 million | +55,409 |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 205,579 | $7.6 million | +40,740 |
| [Harmony Biosciences Hldgs in](https://specstream.ai/data/institutional-holders/harmony-biosciences-hldgs-in-413197104) | COM | 201,036 | $7.3 million | +81,696 |
| [Krystal Biotech Inc](https://specstream.ai/data/institutional-holders/krystal-biotech-inc-501147102) | COM | 19,668 | $7.3 million | No change |
| [Annexon Inc](https://specstream.ai/data/institutional-holders/annexon-inc-03589w102) | COM | 1,242,455 | $7.1 million | -50,000 |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 64,110 | $6.7 million | New |
| [Warner Bros Discovery Inc](https://specstream.ai/data/institutional-holders/warner-bros-discovery-inc-934423104) | COM SER A | 250,000 | $6.7 million | -673,725 |

## New positions in Q2 2026

10 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Alkami Technology Inc](https://specstream.ai/data/institutional-holders/alkami-technology-inc-01644j108) | COM | 600,284 | $10.9 million |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 64,110 | $6.7 million |
| Ultragenyx Pharmaceutical in | COM (call) | 100,000 | $3.3 million |
| Silence Therapeutics PLC | ADS (call) | 300,000 | $3.3 million |
| [Cue Biopharma Inc](https://specstream.ai/data/institutional-holders/cue-biopharma-inc-22978p205) | COM | 93,819 | $3 million |
| [Aclaris Therapeutics Inc](https://specstream.ai/data/institutional-holders/aclaris-therapeutics-inc-00461u105) | COM | 400,000 | $2.1 million |
| Agios Pharmaceuticals Inc | COM (call) | 50,000 | $1.9 million |
| [Monte Rosa Therapeutics Inc](https://specstream.ai/data/institutional-holders/monte-rosa-therapeutics-inc-61225m102) | COM | 56,052 | $1.4 million |
| Tenax Therapeutics Inc | COM NEW (call) | 75,100 | $1.1 million |
| Amylyx Pharmaceuticals Inc | COM (call) | 8,500 | $152,660 |

## Positions exited in Q2 2026

7 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 15,952 | $5.1 million |
| Soleno Therapeutics Inc | COM | 102,125 | $3.4 million |
| [Axsome Therapeutics Inc.](https://specstream.ai/data/institutional-holders/axsome-therapeutics-inc-05464t104) | COM | 20,059 | $3.4 million |
| [Maplight Therapeutics Inc](https://specstream.ai/data/institutional-holders/maplight-therapeutics-inc-56565p103) | COM | 112,115 | $2.3 million |
| [Aardvark Therapeutics Inc](https://specstream.ai/data/institutional-holders/aardvark-therapeutics-inc-002942100) | COM | 316,621 | $1.2 million |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 39,473 | $826,959 |
| [Karyopharm Therapeutics Inc](https://specstream.ai/data/institutional-holders/karyopharm-therapeutics-inc-48576u205) | COM NEW | 52,984 | $295,121 |

## Also on SpecStream

- [Tetragon Partners GP Ltd Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1515070/000091957426005024/0000919574-26-005024-index.htm)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Demolition contractors in the United States](https://specstream.ai/data/businesses/demolition-contractors/united-states)
- [Electricians in the United States](https://specstream.ai/data/businesses/electricians/united-states)
- [Fastener suppliers in the United States](https://specstream.ai/data/businesses/fastener-suppliers/united-states)
- [Genetics practices in the United States](https://specstream.ai/data/businesses/genetics-practices/united-states)
- [Hospital equipment suppliers in the United States](https://specstream.ai/data/businesses/hospital-equipment-suppliers/united-states)
- [Irish pubs in the United States](https://specstream.ai/data/businesses/irish-pubs/united-states)
